Transcendental Meditation practitioners show reduced expression of the Conserved Transcriptional Response to Adversity.
Kenneth G Walton, Supaya Wenuganen, Steven W Cole
Brain, Behavior, & Immunity - Health October 1, 2023 DOI: 10.1016/j.bbih.2023.100672 (opens in new tab) via PubMed
Summary
AI-generated from the abstractLong-term practitioners of Transcendental Meditation (TM) showed reduced expression of genes linked to inflammation and increased activity of antiviral genes, compared to matched controls. The analysis focused on a specific pattern of gene activity called the Conserved Transcriptional Response to Adversity (CTRA), which is typically elevated during chronic stress. In the TM group, inflammation-related transcription factors (NF-κB, AP-1) were less active, while interferon response factors were more active. These findings suggest a potential biological mechanism through which long-term meditation practice might improve health, though further research is needed to confirm causality.
Study at a glance
| Characteristics | Secondary analysis of a case-control study Peer reviewed |
|---|---|
| Sample size | 24 |
| Population | Healthy, 38-year practitioners of Transcendental Meditation technologies and matched controls (mean age 65) |
| Intervention | Transcendental Meditation |
| Topics | Meditation |
| Keywords | Consciousness Human gene expression Public health Social genomics |
| Key finding | Long-term TM practitioners showed lower expression of CTRA indicator genes compared to matched controls. |
Abstract
A recent exploratory study of transcriptional effects of long-term practice of Transcendental Meditation (TM) technologies found evidence for altered expression of genes associated with health and disease. In the present secondary analysis of those data, we test the more specific hypothesis that this sample of long-term practitioners shows a significant reduction in markers of the "Conserved Transcriptional Response to Adversity" (CTRA), an RNA profile characterized by up-regulated inflammation and down-regulated Type I interferon (IFN) activity. Data come from a previously published study providing genome-wide transcriptional profiles of peripheral blood mononuclear cells (PBMC) from healthy, 38-year practitioners of TM technologies and matched controls (n = 12, mean age 65). The current analysis specifically tests for differential expression of a previously established CTRA indicator gene score, with cross-validation by promoter-based bioinformatic analysis of CTRA-typical differences in transcription factor activity and monocyte subset cellular origins. Compared to controls, the TM group showed lower expression of a pre-specified set of CTRA indicator genes. These effects were accompanied by genome-wide indications of down-regulated pro-inflammatory transcription factor activity (NF-κB, AP-1), up-regulated activity of Interferon Response Factors (IRF) and reduced transcriptional activity of classical monocytes. Conclusions: A sample of long-term practitioners of TM showed reduced CTRA gene expression in PBMC compared to matched controls, supporting the likely value of further research to evaluate causality and specificity of this potential mechanism of health benefits in meditators.